amagpharma.com rank 401 |
Number of domains linking to amagpharma.com 2 | semantic flow 0.12 |
Number of links to amagpharma.com 2 | semantic flow 0.12 |
Number of domains linked from amagpharma.com 4 | semantic flow 0.48 |
Number of links from amagpharma.com 6 | semantic flow 0.48 |
Pages with highest topical PageRank pointing to domain.
url / atext / target url | |
---|---|
http://www.amagpharma.com/research-and-growth/grants/ research and growth ↳http://www.amagpharma.com/research-and-growth | |
http://www.amagpharma.com/research-and-growth/clinical-research-for-existing-products/ head to head phase 3 clinical trial ↳http://www.amagpharma.com/research-and-growth/clinical-research-for-existing-products/fera |
On-topic pages from domain with highest topical PageRank.
title / url | |||||||||
---|---|---|---|---|---|---|---|---|---|
Press Release u2013 Investors u2013 AMAG Pharmaceuticals http://ir.amagpharma.com/phoenix.zhtml?c=61596&p=irol-newsArticle&ID=2330242 | 0.21 | 0.68 | 19 | 11 | 0 | 0 | 0 | 0 | |
Business Development u2013 AMAG Pharmaceuticals http://www.amagpharma.com/research-and-growth/business-development/ | 0.18 | 1 | 13 | 9 | 0 | 0 | 0 | 0 | |
Grants u2013 AMAG Pharmaceuticals http://www.amagpharma.com/research-and-growth/grants/ | 0.18 | 0.99 | 15 | 9 | 0 | 0 | 0 | 0 | |
New Therapeutic Development u2013 AMAG Pharmaceuticals http://www.amagpharma.com/research-and-growth/new-therapeutic-development/ | 0.18 | 1 | 14 | 10 | 1 | 1 | 0 | 0 | |
Clinical Research for Existing Products u2013 AMAG Pharmaceuticals http://www.amagpharma.com/research-and-growth/clinical-research-for-existing-products/ | 0.18 | 1 | 19 | 13 | 3 | 1 | 0 | 0 |
Relevant domains with most links to selected domain.
domain | |||
---|---|---|---|
http://biotech-careers.org/ | 1 | 0.07 | biotech-careers.org |
http://fiercepharma.com/ | 1 | 0.05 | fiercepharma.com |
Relevant domains with most links from selected domain.
domain | |||
---|---|---|---|
http://clinicaltrials.gov/ | 3 | 0.25 | clinicaltrials.gov |
http://glenveigh.com/ | 1 | 0.09 | glenveigh.com |
http://silkroad.com/ | 1 | 0.08 | silkroad.com |
http://corporate-ir.net/ | 1 | 0.05 | corporate-ir.net |
Pages from domain with most relevant inbound links.
url | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
http://www.amagpharma.com/working-at-amag/ | 1 | 0.16 | 0.99 | 0.07 | 0.99 | yes | 9 | 7 | 1 | 1 | 0 | 0 | |
http://www.amagpharma.com/working-at-amag/our-employees/ | 1 | 0.16 | 0.99 | 0.07 | 0.53 | yes | 10 | 8 | 1 | 1 | 0 | 0 | |
http://www.amagpharma.com/news/amag-pharmaceuticals-announces-fda-approval-of-supplemental | 1 | 0.16 | 0.99 | 0.07 | 0.69 | yes | 10 | 6 | 0 | 0 | 0 | 0 | |
http://www.amagpharma.com/our-products/ | 1 | 0.16 | 0.99 | 0.07 | -1 | no | -1 | -1 | -1 | -1 | 0 | 0 | |
http://www.amagpharma.com/news/amag-pharmaceuticals-announces-preliminary-2017-financial-r | 1 | 0.16 | 0.98 | 0.07 | -1 | no | -1 | -1 | -1 | -1 | 0 | 0 | |
http://www.amagpharma.com/research-and-growth/ | 1 | 0.16 | 0.99 | 0.07 | 1 | yes | 11 | 9 | 0 | 0 | 0 | 0 | |
http://www.amagpharma.com/ | 1 | 0.15 | 0.93 | 0.07 | 1 | yes | 11 | 9 | 0 | 0 | 1 | 1 | |
http://www.amagpharma.com/corporate-principles/ | 1 | 0.16 | 0.96 | 0.07 | 0.84 | yes | 7 | 5 | 0 | 0 | 0 | 0 | |
http://www.amagpharma.com/newsroom/ | 1 | 0.16 | 0.93 | 0.07 | 1 | yes | 9 | 6 | 0 | 0 | 0 | 0 | |
http://ir.amagpharma.com/phoenix.zhtml?c=61596&p=irol-newsArticle&ID=2211128 | 1 | 0.18 | 0.71 | 0.05 | -1 | - | -1 | -1 | -1 | -1 | 1 | 1 |
Pages from domain with most likely on-topic outgoing links.
url | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
http://www.amagpharma.com/ | 9 | 0.15 | 0.93 | 0.66 | 1 | yes | 11 | 9 | 0 | 0 | 1 | 1 | |
http://ir.amagpharma.com/phoenix.zhtml?c=61596&p=irol-irhome | 8 | 0.16 | 0.98 | 0.58 | 1 | yes | 20 | 13 | 1 | 1 | 0 | 0 | |
http://www.amagpharma.com/research-and-growth/clinical-research-for-existing-products/ | 4 | 0.18 | 0.99 | 0.33 | 1 | yes | 19 | 13 | 3 | 1 | 0 | 0 | |
http://www.amagpharma.com/research-and-growth/ | 4 | 0.16 | 0.99 | 0.32 | 1 | yes | 11 | 9 | 0 | 0 | 0 | 0 | |
http://ir.amagpharma.com/phoenix.zhtml?c=61596&p=irol-news&nyo=0 | 2 | 0.17 | 0.98 | 0.16 | 1 | yes | 24 | 13 | 0 | 0 | 0 | 0 | |
http://www.amagpharma.com/research-and-growth/new-therapeutic-development/ | 1 | 0.18 | 0.99 | 0.09 | 1 | yes | 14 | 10 | 1 | 1 | 0 | 0 | |
http://www.amagpharma.com/research-and-growth/grants/ | 1 | 0.18 | 0.98 | 0.09 | 0.99 | yes | 15 | 9 | 0 | 0 | 0 | 0 | |
http://www.amagpharma.com/working-at-amag/ | 1 | 0.16 | 0.99 | 0.08 | 0.99 | yes | 9 | 7 | 1 | 1 | 0 | 0 | |
http://www.amagpharma.com/news/amag-pharmaceuticals-announces-fda-approval-of-supplemental | 1 | 0.16 | 0.99 | 0.03 | 0.69 | yes | 10 | 6 | 0 | 0 | 0 | 0 | |
http://www.amagpharma.com/working-at-amag/our-employees/ | 1 | 0.16 | 0.99 | 0.03 | 0.53 | yes | 10 | 8 | 1 | 1 | 0 | 0 |
Similar domains to domain, based on inbound linking patterns from other relevant domains. This is also known in SEO as topical co-citation.